论文部分内容阅读
目的：观察卡托普利治疗肺心病心力衰竭的疗效。方法：肺心病心力衰竭６０例（男性４２例、女性１８例；年龄７１±ｓ４ａ）．采用卡托普利６．２５－２５ｍｇ，ｐｏ，ｔｉｄ。待心力衰竭控制后，减量至有效维持量，１－２ｗｋ为一个疗程，其中１６例加用地高辛０．１２５ｍｇ，ｑｄ。另设对照组（单用地高辛０．１２５ｍｇ，ｐｏ，ｑｄ或硝苯地平１０ｍｇ，ｐｏ，ｔｉｄ）６０例作对比。结果：总有效率分别为９０％和８０％，经Ｒｉｄｉｔ分析，２组疗效无明显差异（Ｐ＞０．０５０）．结论：使用卡托普利是一种治疗肺心病心力衰竭的有效药物。
Objective: To observe the curative effect of captopril on heart failure of pulmonary heart disease. Methods: Sixty patients with cor pulmonale heart failure (42 males and 18 females; age 71 ± s4a). Captopril 6.25-25mg, po, tid. Heart failure to be controlled, reduced to the effective maintenance dose, 1-2wk for a course of treatment, of which 16 cases plus digoxin 0.125mg, qd. Another control group (single digoxin 0.125mg, po, qd or nifedipine 10mg, po, tid) for 60 cases for comparison. Results: The total effective rates were 90% and 80% respectively. There was no significant difference between the two groups (P> 0.050) by Ridit analysis. Conclusions: Captopril is an effective drug for the treatment of heart failure due to cor pulmonale.